foxm1 protein Search Results


94
MedChemExpress foxm1
Foxm1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/FOXM1+Antibody/pm41721390-43-3-55
Average 94 stars, based on 1 article reviews
foxm1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress win 55212 2
Survival rates of PQ-injected mice. A Survival rates of PQ-injected mice at 20 mg/kg, 30 mg/kg, and 45 mg/kg administrated with 0 mg/kg, 0.2 mg/kg, or 1 mg/kg <t>WIN</t> <t>55212–2</t> (each group, n = 15). B Kaplan–Meier function for overall survival of WIN 55212–2 administered mice at different doses, followed up to 28 days after PQ treatment (three PQ dose combinations in this experiment and, n = 45, * P < 0.05).
Win 55212 2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/FOXM1%2C+Human/pmc09174632-44-30-32
Average 94 stars, based on 1 article reviews
win 55212 2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
Novus Biologicals recombinant human gst foxm1
Survival rates of PQ-injected mice. A Survival rates of PQ-injected mice at 20 mg/kg, 30 mg/kg, and 45 mg/kg administrated with 0 mg/kg, 0.2 mg/kg, or 1 mg/kg <t>WIN</t> <t>55212–2</t> (each group, n = 15). B Kaplan–Meier function for overall survival of WIN 55212–2 administered mice at different doses, followed up to 28 days after PQ treatment (three PQ dose combinations in this experiment and, n = 45, * P < 0.05).
Recombinant Human Gst Foxm1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/Recombinant+Human+FoxM1+GST+(N-Term)+Protein/pmc08595659-216-0-9
Average 91 stars, based on 1 article reviews
recombinant human gst foxm1 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
OriGene foxm1
Figure 1. <t>FOXM1</t> and MAT1A mRNA levels in HCC and CCA, and their influences on survival curves in HCC. A) Relative FOXM1 and MMP-7 mRNA levels from seven patients with CCA compared to normal liver tissues. *p < 0.05 vs. normal human liver tissues. B) Relative MAT1A and FOXM1 mRNA levels from 143 patients with HCC (TU) compared to adjacent non- tumorous tissues (AD). *p < 0.05 vs. AD. C) Pearson correlation analysis of MAT1A and FOXM1 mRNA levels in 143 HCC specimens and in 52 HCCs with vascular invasion. D) Pearson correlation analysis of FOXM1 and MAT1A mRNA levels in HCC Samples (N=366) from the Cancer Genome Atlas (TCGA) dataset. E and F) Kaplan-Meier survival
Foxm1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/FOXM1+(NM_021953)+Human+Recombinant+Protein/pm32080887-74-30-35
Average 90 stars, based on 1 article reviews
foxm1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas foxm1 protein expression
<t>FOXM1</t> is a direct target of YTHDF1. Normalized expression of target genes detected by RT-qPCR after A RIP, B m6A-IP or C YTHDF1-CLIP assay. D Correlation between <t>FOXM1</t> <t>protein</t> expression and YHTDF1 mRNA expression in TCGA-BRCA dataset. E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas. F The protein and expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. G The correlation between YTHDF1 and FOXM1 in protein levels by immunohistochemical analysis in 9 samples. H The mRNA expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. I Polysome profiling assay in MCF-7 cells transduced with sh-NC or sh-YTHDF1#2 (Left). FOXM1 and 18 s rRNA expression in different polysome fractions (Right). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated
Foxm1 Protein Expression, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/foxm1+protein+expression/pmc08867832-199-0-13
Average 90 stars, based on 1 article reviews
foxm1 protein expression - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Medema labs foxm1 protein
<t>FOXM1</t> is a direct target of YTHDF1. Normalized expression of target genes detected by RT-qPCR after A RIP, B m6A-IP or C YTHDF1-CLIP assay. D Correlation between <t>FOXM1</t> <t>protein</t> expression and YHTDF1 mRNA expression in TCGA-BRCA dataset. E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas. F The protein and expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. G The correlation between YTHDF1 and FOXM1 in protein levels by immunohistochemical analysis in 9 samples. H The mRNA expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. I Polysome profiling assay in MCF-7 cells transduced with sh-NC or sh-YTHDF1#2 (Left). FOXM1 and 18 s rRNA expression in different polysome fractions (Right). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated
Foxm1 Protein, supplied by Medema labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/foxm1+protein/pmc02892325-183-39-23
Average 90 stars, based on 1 article reviews
foxm1 protein - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Fox Head Inc transcription factor family member foxo1
<t>FOXM1</t> is a direct target of YTHDF1. Normalized expression of target genes detected by RT-qPCR after A RIP, B m6A-IP or C YTHDF1-CLIP assay. D Correlation between <t>FOXM1</t> <t>protein</t> expression and YHTDF1 mRNA expression in TCGA-BRCA dataset. E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas. F The protein and expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. G The correlation between YTHDF1 and FOXM1 in protein levels by immunohistochemical analysis in 9 samples. H The mRNA expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. I Polysome profiling assay in MCF-7 cells transduced with sh-NC or sh-YTHDF1#2 (Left). FOXM1 and 18 s rRNA expression in different polysome fractions (Right). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated
Transcription Factor Family Member Foxo1, supplied by Fox Head Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/foxm1+protein/pmc09116905-176-4-3
Average 90 stars, based on 1 article reviews
transcription factor family member foxo1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Hartenstein GmbH foxm1 protein
<t>FOXM1</t> is a direct target of YTHDF1. Normalized expression of target genes detected by RT-qPCR after A RIP, B m6A-IP or C YTHDF1-CLIP assay. D Correlation between <t>FOXM1</t> <t>protein</t> expression and YHTDF1 mRNA expression in TCGA-BRCA dataset. E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas. F The protein and expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. G The correlation between YTHDF1 and FOXM1 in protein levels by immunohistochemical analysis in 9 samples. H The mRNA expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. I Polysome profiling assay in MCF-7 cells transduced with sh-NC or sh-YTHDF1#2 (Left). FOXM1 and 18 s rRNA expression in different polysome fractions (Right). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated
Foxm1 Protein, supplied by Hartenstein GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/foxm1+protein/pm18469223-152-5-47
Average 90 stars, based on 1 article reviews
foxm1 protein - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SMAC Corp foxm1 protein
<t>FOXM1</t> is a direct target of YTHDF1. Normalized expression of target genes detected by RT-qPCR after A RIP, B m6A-IP or C YTHDF1-CLIP assay. D Correlation between <t>FOXM1</t> <t>protein</t> expression and YHTDF1 mRNA expression in TCGA-BRCA dataset. E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas. F The protein and expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. G The correlation between YTHDF1 and FOXM1 in protein levels by immunohistochemical analysis in 9 samples. H The mRNA expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. I Polysome profiling assay in MCF-7 cells transduced with sh-NC or sh-YTHDF1#2 (Left). FOXM1 and 18 s rRNA expression in different polysome fractions (Right). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated
Foxm1 Protein, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/foxm1+protein/10__1158_slash_1078___0432__ccr___17___2074-295-206-209
Average 90 stars, based on 1 article reviews
foxm1 protein - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Human Protein Atlas foxm1
<t>FOXM1</t> promotes the proliferation of HCC cells in vitro . (A) The expression of FOXM1 in tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (B) The expression of Ki-67 in tumor tissues of patients with HCC analyzed by IHC. (C) The differential expression of FOXM1 between tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (D) Correlation analysis of FOXM1 and Ki-67 IHC scores in tumor tissues of patients with HCC. (E) Box plots for the differential expression of FOXM1 between LIHC tissues and adjacent tissues in TCGA. (F) ROC curves for the relationship between FOXM1 expression and the prognosis of HCC patients. (G) Correlation between FOXM1 expression levels and survival of HCC patients. (H) Distribution of FOXM1 mRNA expression in HCC cell lines. (I) Expression of FOXM1 in HUH7, HepG2, and SMMC-7721 cells analyzed by Western blot. (J) Effect of FOXM1 shRNA and FOXM1 cDNA on the viability of HUH7 cells. (K) Effects of FOXM1 on the formation of HUH7 colonies. (L) Effects of FOXM1 on the apoptosis of HUH7 cells. (M) Effects of FDI-6 on the proliferation of HUH7 cells. (N) Effects of FDI-6 on the formation of HUH7 colonies. (O) Effects of FOXM1 shRNA and FOXM1 cDNA on mouse weight. (P) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor volume. (Q) The photos of tumor nodules in each group. (R) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor weight. (S) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor proliferation. (T) The expression of Ki-67 and FOXM1 in xenograft tumor analyzed by IHC. Images were randomly selected from five replicates. Data from three independent experiments were analyzed by one-way ANOVA: * P<0.05, ** P<0.01 vs. control group; # P<0.05, ## P<0.01 vs. FOXM1 KD group.
Foxm1, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/cab017832+foxm1/pmc13050458-52-4-14
Average 86 stars, based on 1 article reviews
foxm1 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
AUTODOCK GmbH molecular docking of fpp29 to the target protein foxm1 (pdb: 3g73)
<t>FOXM1</t> promotes the proliferation of HCC cells in vitro . (A) The expression of FOXM1 in tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (B) The expression of Ki-67 in tumor tissues of patients with HCC analyzed by IHC. (C) The differential expression of FOXM1 between tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (D) Correlation analysis of FOXM1 and Ki-67 IHC scores in tumor tissues of patients with HCC. (E) Box plots for the differential expression of FOXM1 between LIHC tissues and adjacent tissues in TCGA. (F) ROC curves for the relationship between FOXM1 expression and the prognosis of HCC patients. (G) Correlation between FOXM1 expression levels and survival of HCC patients. (H) Distribution of FOXM1 mRNA expression in HCC cell lines. (I) Expression of FOXM1 in HUH7, HepG2, and SMMC-7721 cells analyzed by Western blot. (J) Effect of FOXM1 shRNA and FOXM1 cDNA on the viability of HUH7 cells. (K) Effects of FOXM1 on the formation of HUH7 colonies. (L) Effects of FOXM1 on the apoptosis of HUH7 cells. (M) Effects of FDI-6 on the proliferation of HUH7 cells. (N) Effects of FDI-6 on the formation of HUH7 colonies. (O) Effects of FOXM1 shRNA and FOXM1 cDNA on mouse weight. (P) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor volume. (Q) The photos of tumor nodules in each group. (R) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor weight. (S) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor proliferation. (T) The expression of Ki-67 and FOXM1 in xenograft tumor analyzed by IHC. Images were randomly selected from five replicates. Data from three independent experiments were analyzed by one-way ANOVA: * P<0.05, ** P<0.01 vs. control group; # P<0.05, ## P<0.01 vs. FOXM1 KD group.
Molecular Docking Of Fpp29 To The Target Protein Foxm1 (Pdb: 3g73), supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/foxm1+protein/molecular+docking+of+fpp29+to+the+target+protein+foxm1++pdb++3g73+/10__1016_slash_j__bioorg__2025__108626-268-4-13
Average 90 stars, based on 1 article reviews
molecular docking of fpp29 to the target protein foxm1 (pdb: 3g73) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier


Image Search Results


Survival rates of PQ-injected mice. A Survival rates of PQ-injected mice at 20 mg/kg, 30 mg/kg, and 45 mg/kg administrated with 0 mg/kg, 0.2 mg/kg, or 1 mg/kg WIN 55212–2 (each group, n = 15). B Kaplan–Meier function for overall survival of WIN 55212–2 administered mice at different doses, followed up to 28 days after PQ treatment (three PQ dose combinations in this experiment and, n = 45, * P < 0.05).

Journal: Inflammation

Article Title: Cannabinoid Analogue WIN 55212–2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization

doi: 10.1007/s10753-022-01688-z

Figure Lengend Snippet: Survival rates of PQ-injected mice. A Survival rates of PQ-injected mice at 20 mg/kg, 30 mg/kg, and 45 mg/kg administrated with 0 mg/kg, 0.2 mg/kg, or 1 mg/kg WIN 55212–2 (each group, n = 15). B Kaplan–Meier function for overall survival of WIN 55212–2 administered mice at different doses, followed up to 28 days after PQ treatment (three PQ dose combinations in this experiment and, n = 45, * P < 0.05).

Article Snippet: Three groups of mice (45 mice per group) at different PQ doses (20 mg/kg, 30 mg/kg, and 45 mg/kg) were further divided into nine subgroups according to the administration of WIN 55212–2 (MedChemexpress Co., China), namely the PQ20 (PQ 20 mg/kg) subgroups: [PQ20-WIN 55212–2 (WIN)-0] (the control, n = 15), PQ20-WIN 0.2 mg ( n = 15), and PQ20-WIN 1 mg ( n = 15); PQ30 (PQ 30 mg/kg) subgroups: PQ30-WIN-0 (the control, n = 15), PQ30-WIN 0.2 mg ( n = 15), and PQ30-WIN 1 mg ( n = 15); and PQ45 (PQ 45 mg/kg) subgroups: PQ45-WIN 0 (the control, n = 15), PQ45-WIN 0.2 mg ( n = 15), and PQ45-WIN 1 mg. A single dose of PQ was given trough intraperitoneal (i.p.) injection and following with WIN 55212–2 i.p. injection after 3 h and then every 2 days, for a total of 28 days of WIN 55212–2 treatment.

Techniques: Injection

Analysis of inflammatory cells and protein levels in BALFs collected from control mice and mice injected with PQ with or without administration of WIN 55212–2. A Typical figure of HE staining of BALFs cells. Black arrow, macrophage; green arrow, neutrophil; yellow arrow, leukocyte. B The number of different inflammatory cell subtypes in BALFs. C Total protein levels of different groups. In C and B , * P < 0.05 compared to PQ30-WIN-0 group; # P < 0.05 indicates significant difference compared to control group. D Analysis of M1 and M2 macrophages by cell surface antigen labeling and flow cytometry assay. For all of the assays, dose of PQ was 30 mg/kg, n = 5. * or # P < 0.05 indicates a significant difference.

Journal: Inflammation

Article Title: Cannabinoid Analogue WIN 55212–2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization

doi: 10.1007/s10753-022-01688-z

Figure Lengend Snippet: Analysis of inflammatory cells and protein levels in BALFs collected from control mice and mice injected with PQ with or without administration of WIN 55212–2. A Typical figure of HE staining of BALFs cells. Black arrow, macrophage; green arrow, neutrophil; yellow arrow, leukocyte. B The number of different inflammatory cell subtypes in BALFs. C Total protein levels of different groups. In C and B , * P < 0.05 compared to PQ30-WIN-0 group; # P < 0.05 indicates significant difference compared to control group. D Analysis of M1 and M2 macrophages by cell surface antigen labeling and flow cytometry assay. For all of the assays, dose of PQ was 30 mg/kg, n = 5. * or # P < 0.05 indicates a significant difference.

Article Snippet: Three groups of mice (45 mice per group) at different PQ doses (20 mg/kg, 30 mg/kg, and 45 mg/kg) were further divided into nine subgroups according to the administration of WIN 55212–2 (MedChemexpress Co., China), namely the PQ20 (PQ 20 mg/kg) subgroups: [PQ20-WIN 55212–2 (WIN)-0] (the control, n = 15), PQ20-WIN 0.2 mg ( n = 15), and PQ20-WIN 1 mg ( n = 15); PQ30 (PQ 30 mg/kg) subgroups: PQ30-WIN-0 (the control, n = 15), PQ30-WIN 0.2 mg ( n = 15), and PQ30-WIN 1 mg ( n = 15); and PQ45 (PQ 45 mg/kg) subgroups: PQ45-WIN 0 (the control, n = 15), PQ45-WIN 0.2 mg ( n = 15), and PQ45-WIN 1 mg. A single dose of PQ was given trough intraperitoneal (i.p.) injection and following with WIN 55212–2 i.p. injection after 3 h and then every 2 days, for a total of 28 days of WIN 55212–2 treatment.

Techniques: Control, Injection, Staining, Labeling, Flow Cytometry

Expression assay of inflammatory factors. A ELISA analysis of inflammatory cytokines levels in BALFs collected from control mice and PQ injected mice with or without WIN 55212–2 administration. B Fold change in mRNA expression of TNF-a, IL-6, and IL-10 in lung tissues. C Fold change of mRNA expression of CD163 and CD206 in lung tissues. D Western blot analysis of CD163 and CD206 in lung tissues. PQ dose was 30 mg/kg. n = 5. # P < 0.05 compared with PQ30-WIN-0 group, * P < 0.05 indicates significant difference compared with control group.

Journal: Inflammation

Article Title: Cannabinoid Analogue WIN 55212–2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization

doi: 10.1007/s10753-022-01688-z

Figure Lengend Snippet: Expression assay of inflammatory factors. A ELISA analysis of inflammatory cytokines levels in BALFs collected from control mice and PQ injected mice with or without WIN 55212–2 administration. B Fold change in mRNA expression of TNF-a, IL-6, and IL-10 in lung tissues. C Fold change of mRNA expression of CD163 and CD206 in lung tissues. D Western blot analysis of CD163 and CD206 in lung tissues. PQ dose was 30 mg/kg. n = 5. # P < 0.05 compared with PQ30-WIN-0 group, * P < 0.05 indicates significant difference compared with control group.

Article Snippet: Three groups of mice (45 mice per group) at different PQ doses (20 mg/kg, 30 mg/kg, and 45 mg/kg) were further divided into nine subgroups according to the administration of WIN 55212–2 (MedChemexpress Co., China), namely the PQ20 (PQ 20 mg/kg) subgroups: [PQ20-WIN 55212–2 (WIN)-0] (the control, n = 15), PQ20-WIN 0.2 mg ( n = 15), and PQ20-WIN 1 mg ( n = 15); PQ30 (PQ 30 mg/kg) subgroups: PQ30-WIN-0 (the control, n = 15), PQ30-WIN 0.2 mg ( n = 15), and PQ30-WIN 1 mg ( n = 15); and PQ45 (PQ 45 mg/kg) subgroups: PQ45-WIN 0 (the control, n = 15), PQ45-WIN 0.2 mg ( n = 15), and PQ45-WIN 1 mg. A single dose of PQ was given trough intraperitoneal (i.p.) injection and following with WIN 55212–2 i.p. injection after 3 h and then every 2 days, for a total of 28 days of WIN 55212–2 treatment.

Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Control, Injection, Western Blot

WIN 55212–2 reduced PQ - induced fibrosis and enhance IL-10 and CD206 expression. A – C Q-PCR analysis of TGF-b, a-SMA, Fibronectin, PDGFRα, collagen I, and collagen III exp-ression in different groups of lung tissues. # P < 0.05 compared to the PQ30-WIN-0 group; * P < 0.05 compared to the control group indicates a significant difference; D – E western blot analysis of TGF-b, a-SMA, Fibronectin, Col-I, and PDGFRα expression in different groups of lung tissues; F – I Masson staining and immunohistochemical staining of IL-10 and CD 206 and their relative staining percentage analysis. Collagen fiber was blue staining in Masson staining. IL-10 and CD 206 positive cells were brown staining in IHC DBA development. For each sample, 5 different microscopic fields were quantified by the ImageJ software. PQ dose is 30 mg/kg, n = 5, *or # P < 0.05 indicates a significant difference.

Journal: Inflammation

Article Title: Cannabinoid Analogue WIN 55212–2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization

doi: 10.1007/s10753-022-01688-z

Figure Lengend Snippet: WIN 55212–2 reduced PQ - induced fibrosis and enhance IL-10 and CD206 expression. A – C Q-PCR analysis of TGF-b, a-SMA, Fibronectin, PDGFRα, collagen I, and collagen III exp-ression in different groups of lung tissues. # P < 0.05 compared to the PQ30-WIN-0 group; * P < 0.05 compared to the control group indicates a significant difference; D – E western blot analysis of TGF-b, a-SMA, Fibronectin, Col-I, and PDGFRα expression in different groups of lung tissues; F – I Masson staining and immunohistochemical staining of IL-10 and CD 206 and their relative staining percentage analysis. Collagen fiber was blue staining in Masson staining. IL-10 and CD 206 positive cells were brown staining in IHC DBA development. For each sample, 5 different microscopic fields were quantified by the ImageJ software. PQ dose is 30 mg/kg, n = 5, *or # P < 0.05 indicates a significant difference.

Article Snippet: Three groups of mice (45 mice per group) at different PQ doses (20 mg/kg, 30 mg/kg, and 45 mg/kg) were further divided into nine subgroups according to the administration of WIN 55212–2 (MedChemexpress Co., China), namely the PQ20 (PQ 20 mg/kg) subgroups: [PQ20-WIN 55212–2 (WIN)-0] (the control, n = 15), PQ20-WIN 0.2 mg ( n = 15), and PQ20-WIN 1 mg ( n = 15); PQ30 (PQ 30 mg/kg) subgroups: PQ30-WIN-0 (the control, n = 15), PQ30-WIN 0.2 mg ( n = 15), and PQ30-WIN 1 mg ( n = 15); and PQ45 (PQ 45 mg/kg) subgroups: PQ45-WIN 0 (the control, n = 15), PQ45-WIN 0.2 mg ( n = 15), and PQ45-WIN 1 mg. A single dose of PQ was given trough intraperitoneal (i.p.) injection and following with WIN 55212–2 i.p. injection after 3 h and then every 2 days, for a total of 28 days of WIN 55212–2 treatment.

Techniques: Expressing, Control, Western Blot, Staining, Immunohistochemical staining, Software

Chi-square Test of PQ and  WIN 55212–2  with Status of Mice Survival

Journal: Inflammation

Article Title: Cannabinoid Analogue WIN 55212–2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization

doi: 10.1007/s10753-022-01688-z

Figure Lengend Snippet: Chi-square Test of PQ and WIN 55212–2 with Status of Mice Survival

Article Snippet: Three groups of mice (45 mice per group) at different PQ doses (20 mg/kg, 30 mg/kg, and 45 mg/kg) were further divided into nine subgroups according to the administration of WIN 55212–2 (MedChemexpress Co., China), namely the PQ20 (PQ 20 mg/kg) subgroups: [PQ20-WIN 55212–2 (WIN)-0] (the control, n = 15), PQ20-WIN 0.2 mg ( n = 15), and PQ20-WIN 1 mg ( n = 15); PQ30 (PQ 30 mg/kg) subgroups: PQ30-WIN-0 (the control, n = 15), PQ30-WIN 0.2 mg ( n = 15), and PQ30-WIN 1 mg ( n = 15); and PQ45 (PQ 45 mg/kg) subgroups: PQ45-WIN 0 (the control, n = 15), PQ45-WIN 0.2 mg ( n = 15), and PQ45-WIN 1 mg. A single dose of PQ was given trough intraperitoneal (i.p.) injection and following with WIN 55212–2 i.p. injection after 3 h and then every 2 days, for a total of 28 days of WIN 55212–2 treatment.

Techniques:

Figure 1. FOXM1 and MAT1A mRNA levels in HCC and CCA, and their influences on survival curves in HCC. A) Relative FOXM1 and MMP-7 mRNA levels from seven patients with CCA compared to normal liver tissues. *p < 0.05 vs. normal human liver tissues. B) Relative MAT1A and FOXM1 mRNA levels from 143 patients with HCC (TU) compared to adjacent non- tumorous tissues (AD). *p < 0.05 vs. AD. C) Pearson correlation analysis of MAT1A and FOXM1 mRNA levels in 143 HCC specimens and in 52 HCCs with vascular invasion. D) Pearson correlation analysis of FOXM1 and MAT1A mRNA levels in HCC Samples (N=366) from the Cancer Genome Atlas (TCGA) dataset. E and F) Kaplan-Meier survival

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 1. FOXM1 and MAT1A mRNA levels in HCC and CCA, and their influences on survival curves in HCC. A) Relative FOXM1 and MMP-7 mRNA levels from seven patients with CCA compared to normal liver tissues. *p < 0.05 vs. normal human liver tissues. B) Relative MAT1A and FOXM1 mRNA levels from 143 patients with HCC (TU) compared to adjacent non- tumorous tissues (AD). *p < 0.05 vs. AD. C) Pearson correlation analysis of MAT1A and FOXM1 mRNA levels in 143 HCC specimens and in 52 HCCs with vascular invasion. D) Pearson correlation analysis of FOXM1 and MAT1A mRNA levels in HCC Samples (N=366) from the Cancer Genome Atlas (TCGA) dataset. E and F) Kaplan-Meier survival

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques:

Figure 2. Protein expression of MATα1, FOXM1, p50, and p65 from HCC and CCA, adjacent and normal liver tissues. A) Representative immunohistochemistry (IHC) staining of MATα1, FOXM1, p50, and p65 from normal liver, non-tumorous tissue adjacent to CCA (CCA-AD), CCA (CCA-TU), HCC-AD, and HCC-TU. All are at 200X magnification. Higher magnification (400X) of boxed areas is shown below for each IHC. B) MATα1, FOXM1, p50, and p65 protein levels from three pairs of CCA and adjacent tissues (CCA-AD), and three normal liver specimens on western blotting. Numbers below the blots are densitometric values, expressed as percent of normal liver. *p < 0.05. vs. normal liver; #p < 0.05 vs. adjacent tissues. C) MATα1, FOXM1, p50, and p65 protein levels in four pairs of HCC and adjacent tissues (HCC-AD), and four normal liver specimens on western blotting. *p < 0.05 vs. normal liver tissues; #p < 0.05 vs. adjacent tissues.

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 2. Protein expression of MATα1, FOXM1, p50, and p65 from HCC and CCA, adjacent and normal liver tissues. A) Representative immunohistochemistry (IHC) staining of MATα1, FOXM1, p50, and p65 from normal liver, non-tumorous tissue adjacent to CCA (CCA-AD), CCA (CCA-TU), HCC-AD, and HCC-TU. All are at 200X magnification. Higher magnification (400X) of boxed areas is shown below for each IHC. B) MATα1, FOXM1, p50, and p65 protein levels from three pairs of CCA and adjacent tissues (CCA-AD), and three normal liver specimens on western blotting. Numbers below the blots are densitometric values, expressed as percent of normal liver. *p < 0.05. vs. normal liver; #p < 0.05 vs. adjacent tissues. C) MATα1, FOXM1, p50, and p65 protein levels in four pairs of HCC and adjacent tissues (HCC-AD), and four normal liver specimens on western blotting. *p < 0.05 vs. normal liver tissues; #p < 0.05 vs. adjacent tissues.

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques: Expressing, Immunohistochemistry, Western Blot

Figure 3. Reciprocal regulation between FOXM1/NF-κB and MAT1A. A) Protein levels of MATα1, FOXM1, p50, p65, HNF4, AFP, CYP2E1, and ACTIN were measured using western blotting in primary mouse hepatocytes at the time of isolation (0 hour = 0h) and up to 6 hours (6h) after plating. B) Protein levels of MATα1, FOXM1, p50 and p65 after overexpressing wild type MAT1A (1A OV), catalytic mutant of MAT1A (1Am) or siRNA knockdown (1A si) as compared to empty vector (EV) or scramble (SC) controls, respectively, in HepG2 cells. Numbers below the blots are densitometric values, expressed as percent of EV or SC in mean ± SEM from three experiments. *p < 0.05 vs. EV or SC; #p<0.05 vs. 1Am. C-D) Protein levels of MATα1, FOXM1, p50, and p65 after FOXM1 expression (FOXM1 OV) or siRNA knockdown (FOXM1 si) in HepG2 (C) and SAMe-D cells, which were also co-transfected with EV or MAT1A (D). Numbers below the blots are densitometric values, expressed as percent of EV or SC. Results are expressed as mean percent of control ± SEM from three experiments. *p < 0.05 vs. respective controls. E)

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 3. Reciprocal regulation between FOXM1/NF-κB and MAT1A. A) Protein levels of MATα1, FOXM1, p50, p65, HNF4, AFP, CYP2E1, and ACTIN were measured using western blotting in primary mouse hepatocytes at the time of isolation (0 hour = 0h) and up to 6 hours (6h) after plating. B) Protein levels of MATα1, FOXM1, p50 and p65 after overexpressing wild type MAT1A (1A OV), catalytic mutant of MAT1A (1Am) or siRNA knockdown (1A si) as compared to empty vector (EV) or scramble (SC) controls, respectively, in HepG2 cells. Numbers below the blots are densitometric values, expressed as percent of EV or SC in mean ± SEM from three experiments. *p < 0.05 vs. EV or SC; #p<0.05 vs. 1Am. C-D) Protein levels of MATα1, FOXM1, p50, and p65 after FOXM1 expression (FOXM1 OV) or siRNA knockdown (FOXM1 si) in HepG2 (C) and SAMe-D cells, which were also co-transfected with EV or MAT1A (D). Numbers below the blots are densitometric values, expressed as percent of EV or SC. Results are expressed as mean percent of control ± SEM from three experiments. *p < 0.05 vs. respective controls. E)

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques: Western Blot, Isolation, Mutagenesis, Knockdown, Plasmid Preparation, Expressing, Transfection, Control

Figure 4. Interaction between FOXM1 and MATα1. A) In vitro pull-down assay using immobilized recombinant MATα1 or FOXM1 and Immunoblot (IB) for MATα1 and FOXM1. B) Western blotting and co-immunoprecipitation (Co-IP) were used to detect MATα1 and FOXM1 protein levels and their interactions in human HCC and adjacent tissues (AD). C) MATα1 and FOXM1 protein levels and their interactions in mouse CCA and control livers.

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 4. Interaction between FOXM1 and MATα1. A) In vitro pull-down assay using immobilized recombinant MATα1 or FOXM1 and Immunoblot (IB) for MATα1 and FOXM1. B) Western blotting and co-immunoprecipitation (Co-IP) were used to detect MATα1 and FOXM1 protein levels and their interactions in human HCC and adjacent tissues (AD). C) MATα1 and FOXM1 protein levels and their interactions in mouse CCA and control livers.

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques: In Vitro, Pull Down Assay, Recombinant, Western Blot, Immunoprecipitation, Co-Immunoprecipitation Assay, Control

Figure 5. FOXM1 and NF-κB regulate MAT1A expression through FOX binding sites. A) EMSA was done using labeled probes containing three FOX binding motifs of the MAT1A promoter as shown above and 100ng of recombinant FOXM1, MATα1, p50, p65, PHB1 alone or combined (left panel), nuclear proteins (0.2μg) from HCC, CCA, and respective adjacent non-tumorous tissues (AD) (middle panel), and with supershift using antibodies to MATα1, p50, FOXM1, and p65 (right panel). Results represent three or more independent experiments. Probe and IgG only served as negative controls. B) MAT1A promoter activity was measured in HepG2 cells following transient transfection with serial deletion constructs. Cells were treated during the last 24 hours of the transfection with DMSO or FDI-6 (5μM). Results represent mean ± SEM from four experiments done in triplicates, *p < 0.05 vs. DMSO. C) FOX binding sites and their mutants in the human MAT1A promoter were created as described in Materials and Methods. D). Effect of T0 (5μM) on the wild type MAT1A promoter (−839/30, 1A WT) or MAT1A promoter mutated

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 5. FOXM1 and NF-κB regulate MAT1A expression through FOX binding sites. A) EMSA was done using labeled probes containing three FOX binding motifs of the MAT1A promoter as shown above and 100ng of recombinant FOXM1, MATα1, p50, p65, PHB1 alone or combined (left panel), nuclear proteins (0.2μg) from HCC, CCA, and respective adjacent non-tumorous tissues (AD) (middle panel), and with supershift using antibodies to MATα1, p50, FOXM1, and p65 (right panel). Results represent three or more independent experiments. Probe and IgG only served as negative controls. B) MAT1A promoter activity was measured in HepG2 cells following transient transfection with serial deletion constructs. Cells were treated during the last 24 hours of the transfection with DMSO or FDI-6 (5μM). Results represent mean ± SEM from four experiments done in triplicates, *p < 0.05 vs. DMSO. C) FOX binding sites and their mutants in the human MAT1A promoter were created as described in Materials and Methods. D). Effect of T0 (5μM) on the wild type MAT1A promoter (−839/30, 1A WT) or MAT1A promoter mutated

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques: Expressing, Binding Assay, Labeling, Recombinant, Activity Assay, Transfection, Construct

Figure 6. Effects of MAT1A and p65 on the FOXM1 promoter. A) HepG2 cells were treated with MAT1A OV or si, or FOXM1 OV or si, and respective controls for 24 hours. ChIP analysis with anti-FOXM1 or MATα1 antibody, and then re- ChIP with anti-MATα1, p65, p50 antibodies after FOXM1 ChIP were performed as described in Materials and Methods. Representative results from three experiments are shown. B) Activities of the wild-type (WT) and FOX binding site mutants (MU) of the FOXM1 promoter after MAT1A OV and si treatment for 24 hours in HepG2 cell. Results are expressed as mean % of EV or SC ± SEM from three experiments done in duplicates *p < 0.05 vs. EV or. SC. C) Promoter activities of the WT and FOX binding site MU of the FOXM1 promoter after p65 OV for 24 hours in the HepG2 cell. Results are expressed as mean % of EV ± SEM from three experiments done in duplicates. *p < 0.05 vs. EV. Results represent at least three independent experiments done in duplicate.

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 6. Effects of MAT1A and p65 on the FOXM1 promoter. A) HepG2 cells were treated with MAT1A OV or si, or FOXM1 OV or si, and respective controls for 24 hours. ChIP analysis with anti-FOXM1 or MATα1 antibody, and then re- ChIP with anti-MATα1, p65, p50 antibodies after FOXM1 ChIP were performed as described in Materials and Methods. Representative results from three experiments are shown. B) Activities of the wild-type (WT) and FOX binding site mutants (MU) of the FOXM1 promoter after MAT1A OV and si treatment for 24 hours in HepG2 cell. Results are expressed as mean % of EV or SC ± SEM from three experiments done in duplicates *p < 0.05 vs. EV or. SC. C) Promoter activities of the WT and FOX binding site MU of the FOXM1 promoter after p65 OV for 24 hours in the HepG2 cell. Results are expressed as mean % of EV ± SEM from three experiments done in duplicates. *p < 0.05 vs. EV. Results represent at least three independent experiments done in duplicate.

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques: Binding Assay

Figure 7. Effects of MAT1A and FOXM1 on cell proliferation, migration and invasion. A) Effects of varying MAT1A and FOXM1 expressions on HepG2 cell migration. Quantitative values are summarized in the graph to the right. Results are expressed as mean % of respective controls ± SEM from three experiments done in duplicates. *p < 0.05 vs. EV +EV or SC+SC; #p < 0.05 vs. FOXM1 OV or siRNA; †p < 0.05 vs. MAT1A OV or siRNA. B) Dose-response effect of FDI-6 treatment on the MTT assay in HepG2 cells. Results are expressed as mean % of DMSO ± SEM from three experiments done in duplicates. *p < 0.05 vs. DMSO; #p < 0.05 vs FDI-6 (10uM). C) Time-dependent effect of FDI-6 (5uM) treatment on the MTT assay in OKER and SAMe-D cells. Results are expressed as mean % of DMSO ± SEM from three experiments done in duplicates. *p < 0.05 vs. DMSO. D) Representative invasion images of OKER and SAMe-D cells after FDI-6 (5uM) treatment. Quantitative analysis is summarized in the graph to the right. Results are expressed as mean % of DMSO ± SEM from three experiments done in duplicates. *p < 0.05 vs. DMSO. E)

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 7. Effects of MAT1A and FOXM1 on cell proliferation, migration and invasion. A) Effects of varying MAT1A and FOXM1 expressions on HepG2 cell migration. Quantitative values are summarized in the graph to the right. Results are expressed as mean % of respective controls ± SEM from three experiments done in duplicates. *p < 0.05 vs. EV +EV or SC+SC; #p < 0.05 vs. FOXM1 OV or siRNA; †p < 0.05 vs. MAT1A OV or siRNA. B) Dose-response effect of FDI-6 treatment on the MTT assay in HepG2 cells. Results are expressed as mean % of DMSO ± SEM from three experiments done in duplicates. *p < 0.05 vs. DMSO; #p < 0.05 vs FDI-6 (10uM). C) Time-dependent effect of FDI-6 (5uM) treatment on the MTT assay in OKER and SAMe-D cells. Results are expressed as mean % of DMSO ± SEM from three experiments done in duplicates. *p < 0.05 vs. DMSO. D) Representative invasion images of OKER and SAMe-D cells after FDI-6 (5uM) treatment. Quantitative analysis is summarized in the graph to the right. Results are expressed as mean % of DMSO ± SEM from three experiments done in duplicates. *p < 0.05 vs. DMSO. E)

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques: Migration, MTT Assay

Figure 8. Effects of T0 and FDI-6 on expression of MATα1, FOXM1, p50 and p65, and tumor growth. A) MATα1, FOXM1, p50, and p65 levels after T0 treatment (5μM) in HepG2 cells. Results are expressed as mean % of DMSO control ± SEM from three experiments done in duplicates. *p<0.05 vs. DMSO. B) Representative pictures of liver xenograft tumors at day 28 after injection of HepG2 cells in DMSO (left) and T0 treatment (right) groups. Results are expressed as mean % of DMSO from n=8 per group. C) FOXM1 and MAT1A mRNA levels from T0 (25 mg/kg/d) or DMSO treated xenograft tumor tissues. Results are expressed as mean % of control ± SEM from eight mice/group. D) Representative H&E and IHC pictures are shown from n = 8 each. Original magnification for H&E and IHCs is X200. E) Protein expression of MATα1, FOXM1, p50, and p65 after FDI-6 treatment in HepG2 cells. Results are expressed as mean % of control ± SEM from three experiments done in triplicates. *p < 0.05 vs. DMSO. F) Representative pictures of liver syngeneic tumors at day 11 after injection of OKER cells in DMSO (left) and FDI-6 treatment (right, 25 mg/kg/d

Journal: Hepatology (Baltimore, Md.)

Article Title: Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.

doi: 10.1002/hep.31196

Figure Lengend Snippet: Figure 8. Effects of T0 and FDI-6 on expression of MATα1, FOXM1, p50 and p65, and tumor growth. A) MATα1, FOXM1, p50, and p65 levels after T0 treatment (5μM) in HepG2 cells. Results are expressed as mean % of DMSO control ± SEM from three experiments done in duplicates. *p<0.05 vs. DMSO. B) Representative pictures of liver xenograft tumors at day 28 after injection of HepG2 cells in DMSO (left) and T0 treatment (right) groups. Results are expressed as mean % of DMSO from n=8 per group. C) FOXM1 and MAT1A mRNA levels from T0 (25 mg/kg/d) or DMSO treated xenograft tumor tissues. Results are expressed as mean % of control ± SEM from eight mice/group. D) Representative H&E and IHC pictures are shown from n = 8 each. Original magnification for H&E and IHCs is X200. E) Protein expression of MATα1, FOXM1, p50, and p65 after FDI-6 treatment in HepG2 cells. Results are expressed as mean % of control ± SEM from three experiments done in triplicates. *p < 0.05 vs. DMSO. F) Representative pictures of liver syngeneic tumors at day 11 after injection of OKER cells in DMSO (left) and FDI-6 treatment (right, 25 mg/kg/d

Article Snippet: Migration and invasion assays Migration and invasion assays were performed as described. (29) MATα1 and FOXM1 interaction Recombinant human MATα1 (CAT#: enz-493-b) was purchased from PROSPEC (East Brunswick NJ) and FOXM1 (CAT#: TP76157 was from OriGENE (Rockville, MD).

Techniques: Expressing, Control, Injection

FOXM1 is a direct target of YTHDF1. Normalized expression of target genes detected by RT-qPCR after A RIP, B m6A-IP or C YTHDF1-CLIP assay. D Correlation between FOXM1 protein expression and YHTDF1 mRNA expression in TCGA-BRCA dataset. E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas. F The protein and expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. G The correlation between YTHDF1 and FOXM1 in protein levels by immunohistochemical analysis in 9 samples. H The mRNA expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. I Polysome profiling assay in MCF-7 cells transduced with sh-NC or sh-YTHDF1#2 (Left). FOXM1 and 18 s rRNA expression in different polysome fractions (Right). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Journal: Cell & Bioscience

Article Title: YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner

doi: 10.1186/s13578-022-00759-w

Figure Lengend Snippet: FOXM1 is a direct target of YTHDF1. Normalized expression of target genes detected by RT-qPCR after A RIP, B m6A-IP or C YTHDF1-CLIP assay. D Correlation between FOXM1 protein expression and YHTDF1 mRNA expression in TCGA-BRCA dataset. E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas. F The protein and expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. G The correlation between YTHDF1 and FOXM1 in protein levels by immunohistochemical analysis in 9 samples. H The mRNA expression of YTHDF1 and FOXM1 in MDA-MB-231 and MCF-7 cells transduced with sh-NC, sh-YTHDF1#1 or sh-YTHDF1#2. I Polysome profiling assay in MCF-7 cells transduced with sh-NC or sh-YTHDF1#2 (Left). FOXM1 and 18 s rRNA expression in different polysome fractions (Right). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Article Snippet: E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas.

Techniques: Expressing, Quantitative RT-PCR, Transduction, Immunohistochemical staining

YTHDF1 regulates FOXM1 expression in an m 6 A-dependent manner. A The analysis of qPCR for FOXM1 expression in RIP assay (anti-Flag) in MDB-MA-231 and MCF-7 cells. B FOXM1 protein expression detected by western blot in MDB-MA-231 and MCF-7 cells transfected with YTHDF1-WT or YTHDF1-MUT plasmids. C Schematic image of FOXM1-WT plasmids, and FOXM1-MUT plasmids containing m 6 A motif mutations in the CDS region. D Protein expression of HA tagged FOXM1 in MDA-MB-231 and MCF-7 cells co-transfected with empty vector, YTHDF1-WT or YTHDF1-MUT, and FOXM1-WT or FOXM1-MUT plasmids. All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Journal: Cell & Bioscience

Article Title: YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner

doi: 10.1186/s13578-022-00759-w

Figure Lengend Snippet: YTHDF1 regulates FOXM1 expression in an m 6 A-dependent manner. A The analysis of qPCR for FOXM1 expression in RIP assay (anti-Flag) in MDB-MA-231 and MCF-7 cells. B FOXM1 protein expression detected by western blot in MDB-MA-231 and MCF-7 cells transfected with YTHDF1-WT or YTHDF1-MUT plasmids. C Schematic image of FOXM1-WT plasmids, and FOXM1-MUT plasmids containing m 6 A motif mutations in the CDS region. D Protein expression of HA tagged FOXM1 in MDA-MB-231 and MCF-7 cells co-transfected with empty vector, YTHDF1-WT or YTHDF1-MUT, and FOXM1-WT or FOXM1-MUT plasmids. All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Article Snippet: E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas.

Techniques: Expressing, Western Blot, Transfection, Plasmid Preparation

The anti-tumor effect of YTHDF1 silence could be abrogated by FOXM1 overexpression. A Western blot analysis for FOXM1 and YTHDF1 in MDB-MA-231 and MCF-7 cells with sh-YTHDF1-2 (shYTH) or sh-YTHDF1#2 + pcDNA-FOXM1 plasmid (shYTH + FOXM1) B CCK-8 assay, C Transwell invasion assay, D wound healing assay and E Western blot assay for EMT-related proteins in MDB-MA-231 and MCF-7 cells with shNC, sh-YTHDF1#2 (shYTH) or sh-YTHDF1#2 + FOXM1 (shYTH + FOXM1). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Journal: Cell & Bioscience

Article Title: YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner

doi: 10.1186/s13578-022-00759-w

Figure Lengend Snippet: The anti-tumor effect of YTHDF1 silence could be abrogated by FOXM1 overexpression. A Western blot analysis for FOXM1 and YTHDF1 in MDB-MA-231 and MCF-7 cells with sh-YTHDF1-2 (shYTH) or sh-YTHDF1#2 + pcDNA-FOXM1 plasmid (shYTH + FOXM1) B CCK-8 assay, C Transwell invasion assay, D wound healing assay and E Western blot assay for EMT-related proteins in MDB-MA-231 and MCF-7 cells with shNC, sh-YTHDF1#2 (shYTH) or sh-YTHDF1#2 + FOXM1 (shYTH + FOXM1). All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Article Snippet: E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas.

Techniques: Over Expression, Western Blot, Plasmid Preparation, CCK-8 Assay, Transwell Invasion Assay, Wound Healing Assay

YTHDF1 overexpression could not reverse the anti-tumor effects caused by FOXM1 knockdown in MCF-7 cells. A CCK-8 assays in shNC, shYTHDF1#2 + FOXM1-WT and sh-YTHDF1#2 + FOXM1-MUT MCF-7 cells. B Western blots for EMT-related proteins and C Transwell invasion assays in shNC, shNC + Vector, sh-YTHDF1#2 + FOXM1-MUT and sh-YTHDF1#2 + FOXM1-WT MCF-7 cells. D FOXM1 protein expression in shNC, sh-FOXM1#1 and sh-FOXM1#2 transduced cells. E Western blots for EMT-related proteins, F CCK-8 assays and G Transwell invasion assays in shNC + Vector, sh-YTHDF1#2 + FOXM1-MUT and sh-YTHDF1#2 + FOXM1-WT MCF-7 cells. All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Journal: Cell & Bioscience

Article Title: YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner

doi: 10.1186/s13578-022-00759-w

Figure Lengend Snippet: YTHDF1 overexpression could not reverse the anti-tumor effects caused by FOXM1 knockdown in MCF-7 cells. A CCK-8 assays in shNC, shYTHDF1#2 + FOXM1-WT and sh-YTHDF1#2 + FOXM1-MUT MCF-7 cells. B Western blots for EMT-related proteins and C Transwell invasion assays in shNC, shNC + Vector, sh-YTHDF1#2 + FOXM1-MUT and sh-YTHDF1#2 + FOXM1-WT MCF-7 cells. D FOXM1 protein expression in shNC, sh-FOXM1#1 and sh-FOXM1#2 transduced cells. E Western blots for EMT-related proteins, F CCK-8 assays and G Transwell invasion assays in shNC + Vector, sh-YTHDF1#2 + FOXM1-MUT and sh-YTHDF1#2 + FOXM1-WT MCF-7 cells. All data were presented as means ± SD of at least three independent repetitions. Values are significant at *P < 0.05, **P < 0.01, ***P < 0.001 as indicated

Article Snippet: E FOXM1 protein expression in breast cancer tissue and normal tissue from The Human Protein Atlas.

Techniques: Over Expression, Knockdown, CCK-8 Assay, Western Blot, Plasmid Preparation, Expressing

FOXM1 promotes the proliferation of HCC cells in vitro . (A) The expression of FOXM1 in tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (B) The expression of Ki-67 in tumor tissues of patients with HCC analyzed by IHC. (C) The differential expression of FOXM1 between tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (D) Correlation analysis of FOXM1 and Ki-67 IHC scores in tumor tissues of patients with HCC. (E) Box plots for the differential expression of FOXM1 between LIHC tissues and adjacent tissues in TCGA. (F) ROC curves for the relationship between FOXM1 expression and the prognosis of HCC patients. (G) Correlation between FOXM1 expression levels and survival of HCC patients. (H) Distribution of FOXM1 mRNA expression in HCC cell lines. (I) Expression of FOXM1 in HUH7, HepG2, and SMMC-7721 cells analyzed by Western blot. (J) Effect of FOXM1 shRNA and FOXM1 cDNA on the viability of HUH7 cells. (K) Effects of FOXM1 on the formation of HUH7 colonies. (L) Effects of FOXM1 on the apoptosis of HUH7 cells. (M) Effects of FDI-6 on the proliferation of HUH7 cells. (N) Effects of FDI-6 on the formation of HUH7 colonies. (O) Effects of FOXM1 shRNA and FOXM1 cDNA on mouse weight. (P) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor volume. (Q) The photos of tumor nodules in each group. (R) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor weight. (S) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor proliferation. (T) The expression of Ki-67 and FOXM1 in xenograft tumor analyzed by IHC. Images were randomly selected from five replicates. Data from three independent experiments were analyzed by one-way ANOVA: * P<0.05, ** P<0.01 vs. control group; # P<0.05, ## P<0.01 vs. FOXM1 KD group.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: FOXM1 promotes the proliferation of HCC cells in vitro . (A) The expression of FOXM1 in tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (B) The expression of Ki-67 in tumor tissues of patients with HCC analyzed by IHC. (C) The differential expression of FOXM1 between tumor tissues and adjacent tissues of patients with HCC analyzed by IHC. (D) Correlation analysis of FOXM1 and Ki-67 IHC scores in tumor tissues of patients with HCC. (E) Box plots for the differential expression of FOXM1 between LIHC tissues and adjacent tissues in TCGA. (F) ROC curves for the relationship between FOXM1 expression and the prognosis of HCC patients. (G) Correlation between FOXM1 expression levels and survival of HCC patients. (H) Distribution of FOXM1 mRNA expression in HCC cell lines. (I) Expression of FOXM1 in HUH7, HepG2, and SMMC-7721 cells analyzed by Western blot. (J) Effect of FOXM1 shRNA and FOXM1 cDNA on the viability of HUH7 cells. (K) Effects of FOXM1 on the formation of HUH7 colonies. (L) Effects of FOXM1 on the apoptosis of HUH7 cells. (M) Effects of FDI-6 on the proliferation of HUH7 cells. (N) Effects of FDI-6 on the formation of HUH7 colonies. (O) Effects of FOXM1 shRNA and FOXM1 cDNA on mouse weight. (P) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor volume. (Q) The photos of tumor nodules in each group. (R) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor weight. (S) Effects of FOXM1 shRNA and FOXM1 cDNA on tumor proliferation. (T) The expression of Ki-67 and FOXM1 in xenograft tumor analyzed by IHC. Images were randomly selected from five replicates. Data from three independent experiments were analyzed by one-way ANOVA: * P<0.05, ** P<0.01 vs. control group; # P<0.05, ## P<0.01 vs. FOXM1 KD group.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: In Vitro, Expressing, Quantitative Proteomics, Western Blot, shRNA, Control

FOXM1-regulated genes involve in DNA repair, cell cycle, stemness and EMT. (A) GO function and KEGG pathway enrichment analysis of DEGs between FOXM1 KD and NC KD in HUH7 cells. (B) . GO function and KEGG pathway enrichment analysis of top 50 targets in the PPI network of FOXM1. (C) . Volcano plot for the DEGs involved in DNA repair and cell cycle analyzed by RNA-seq. (D) Volcano plot for the DEGs involved in cell stemness, invasion and migration. (E) . The relationship between FOXM1 expression and HCC cell stemness in TCGA. (F) . Differential expression of genes between LIHC tissues and adjacent tissues in TCGA. (G) . ROC curves for the relationship between gene expression and HCC prognosis. Data were statistically analyzed using one-way ANOVA: * P<0.05 compared with adjacent tissues.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: FOXM1-regulated genes involve in DNA repair, cell cycle, stemness and EMT. (A) GO function and KEGG pathway enrichment analysis of DEGs between FOXM1 KD and NC KD in HUH7 cells. (B) . GO function and KEGG pathway enrichment analysis of top 50 targets in the PPI network of FOXM1. (C) . Volcano plot for the DEGs involved in DNA repair and cell cycle analyzed by RNA-seq. (D) Volcano plot for the DEGs involved in cell stemness, invasion and migration. (E) . The relationship between FOXM1 expression and HCC cell stemness in TCGA. (F) . Differential expression of genes between LIHC tissues and adjacent tissues in TCGA. (G) . ROC curves for the relationship between gene expression and HCC prognosis. Data were statistically analyzed using one-way ANOVA: * P<0.05 compared with adjacent tissues.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: RNA Sequencing, Migration, Expressing, Quantitative Proteomics, Gene Expression

FOXM1 promotes DNA repair and G2/M progression on HCC cells. (A) Effects of FOXM1 on DNA damage in HUH7 and HepG2 cells analyzed by comet assay. (B) Effects of FOXM1 on γH2AX expression analyzed by IF. (C) Q-PCR analysis of the effects of FOXM1 on the expression of DNA repair-related genes. (D) Analysis of the correlation between FOXM1 and DNA repair-related gene expressions in LIHC. (E) Effects of FOXM1 on cell cycle progression in HUH7 cells. (F) percentage of cell cycle at G0/G1, S, and G2/M phases. (G) Q-PCR analysis of the effects of FOXM1 on the expression of genes regulating G2/M transition. (H) Analysis of the correlation between FOXM1 and cell cycle related gene expressions in HCC. (I) Effects of FDI-6 on DNA damage in HUH7 cells. (J) Effects of FDI-6 on the expression of DNA-repair related genes in HUH7 cells. (K) Effects of FDI-6 on cell cycle progression in HUH7 cells. (L) Effects of FDI-6 on cell cycle-related genes in HUH7 cells. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P < 0.05, ** P < 0.01 vs. NC KD group; # P < 0.05, ## P < 0.01 vs. FOXM1 KD group.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: FOXM1 promotes DNA repair and G2/M progression on HCC cells. (A) Effects of FOXM1 on DNA damage in HUH7 and HepG2 cells analyzed by comet assay. (B) Effects of FOXM1 on γH2AX expression analyzed by IF. (C) Q-PCR analysis of the effects of FOXM1 on the expression of DNA repair-related genes. (D) Analysis of the correlation between FOXM1 and DNA repair-related gene expressions in LIHC. (E) Effects of FOXM1 on cell cycle progression in HUH7 cells. (F) percentage of cell cycle at G0/G1, S, and G2/M phases. (G) Q-PCR analysis of the effects of FOXM1 on the expression of genes regulating G2/M transition. (H) Analysis of the correlation between FOXM1 and cell cycle related gene expressions in HCC. (I) Effects of FDI-6 on DNA damage in HUH7 cells. (J) Effects of FDI-6 on the expression of DNA-repair related genes in HUH7 cells. (K) Effects of FDI-6 on cell cycle progression in HUH7 cells. (L) Effects of FDI-6 on cell cycle-related genes in HUH7 cells. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P < 0.05, ** P < 0.01 vs. NC KD group; # P < 0.05, ## P < 0.01 vs. FOXM1 KD group.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: Single Cell Gel Electrophoresis, Expressing

FOXM1 drives cell stemness, invasion, and migration in HCC cells. (A) Effects of FOXM1 on CD44 expression analyzed by IF in HUH7 cells. (B) Effects of FOXM1 on CD44 expression in HepG2 cells. (C) Effects of FOXM1 on the expression of stemness-related genes in HUH7 cells. (D) Effects of FDI-6 on CD44 expression in HUH7 cells. (E) Effects of FDI-6 on the expression of stemness-related genes in HUH7 cells. (F) Effects of FOXM1 shRNA and FDI-6 on the formation of HUH7 three-dimensional spheres. (G) Analysis of the correlation between FOXM1 and cell cycle-related gene expressions in HCC. (H) Effects of FOXM1 on the invasion and migration of HUH7 and HepG2 cells. (I) Q-PCR analysis of the effects of FOXM1 on EMT-related gene expression in HUH7 cells. (J) Effects of FDI-6 on the invasion and migration of HUH7 cells. (K) Q-PCR analysis of the effects of FDI-6 on EMT-related gene expression in HUH7 cells. (L) Analysis of the correlation between FOXM1 and EMT-related gene expressions in HCC. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P < 0.05, ** P < 0.01 vs. NC KD group; # P < 0.05, ## P < 0.01 vs. FOXM1 KD group.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: FOXM1 drives cell stemness, invasion, and migration in HCC cells. (A) Effects of FOXM1 on CD44 expression analyzed by IF in HUH7 cells. (B) Effects of FOXM1 on CD44 expression in HepG2 cells. (C) Effects of FOXM1 on the expression of stemness-related genes in HUH7 cells. (D) Effects of FDI-6 on CD44 expression in HUH7 cells. (E) Effects of FDI-6 on the expression of stemness-related genes in HUH7 cells. (F) Effects of FOXM1 shRNA and FDI-6 on the formation of HUH7 three-dimensional spheres. (G) Analysis of the correlation between FOXM1 and cell cycle-related gene expressions in HCC. (H) Effects of FOXM1 on the invasion and migration of HUH7 and HepG2 cells. (I) Q-PCR analysis of the effects of FOXM1 on EMT-related gene expression in HUH7 cells. (J) Effects of FDI-6 on the invasion and migration of HUH7 cells. (K) Q-PCR analysis of the effects of FDI-6 on EMT-related gene expression in HUH7 cells. (L) Analysis of the correlation between FOXM1 and EMT-related gene expressions in HCC. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P < 0.05, ** P < 0.01 vs. NC KD group; # P < 0.05, ## P < 0.01 vs. FOXM1 KD group.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: Migration, Expressing, shRNA, Gene Expression

FOXM1 promotes BUB1 expression at transcriptional level. (A) Venn diagram of overlapping genes identified by RNA-seq and FOXM1 PPI network. (B) Analysis the association between key gene expression and HCC patient survival. (C) The expression of BUB1 between HCC tissues and adjacent tissues from clinical patients analyzed by IHC. (D) IHC scores of BUB1 between HCC tissues and adjacent tissues from clinical patients. (E) Correlation analysis of BUB1 and Ki-67 IHC scores in tumor tissues of patients with HCC. (F) Correlation analysis of BUB1 and FOXM1 IHC scores in tumor tissues of patients with HCC. (G) Co-IP analysis of the interaction between FOXM1 and BUB1 in HUH7 cells. (H) Effects of FOXM1 shRNA and BUB1 shRNA on the expression of FOXM1 and BUB1 analyzed by Q-PCR. (I) The expression of FOXM1 and BUB1 analyzed by Western blot. (J) ChIP-qPCR analysis of the binding of FOXM1 and BUB1 promoter in HUH7 cells. (K) The sequences at the -293 bp of the BUB1-WT promoter and the BUB1-Mut promoter. (L) The binding of FOXM1 and BUB1 promoter at the -293 bp sequence GTAAACC analyzed by dual luciferase reporter assay. (M) Q-PCR analysis of BUB1 expression in different HCC cells. (N) Western blot analysis of BUB1 expression in different HCC cells. (O) KEGG pathway enrichment analysis of top 50 targets in the PPI network of BUB1. (P) Venn diagram of overlapping genes identified by RNA-seq, FOXM1 PPI network, and BUB1 PPI network. (Q) correlation analysis of BUB1 expression and LIHC cell stemness in TCGA. (R) Effect of BUB1 on the inhibitory role of FOXM1 shRNA in the proliferation of HUH7 cells. (S) Effects of BUB1 on the inhibition of FOXM1 shRNA in HUH7 colony formation. (T) Effects of BUB1 on the promotion of FOXM1 shRNA in HUH7 cell apoptosis. (U) Effects of BUB1 shRNA on HUH7 xenograft tumor volumes. (V) Photos of HUH7 xenograft tumors in each group. (W) Effects of BUB1 shRNA on HUH7 xenograft tumor weight. (X) Effects of BUB1 shRNA on Ki-67 and BUB1 expression in each group. Images were randomly selected from five replicates. Data from three independent experiments were analyzed by one-way ANOVA: * P<0.05, ** P<0.01 vs. NC KD group, # P < 0.05, ## P < 0.01 vs. FOXM1 KD group.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: FOXM1 promotes BUB1 expression at transcriptional level. (A) Venn diagram of overlapping genes identified by RNA-seq and FOXM1 PPI network. (B) Analysis the association between key gene expression and HCC patient survival. (C) The expression of BUB1 between HCC tissues and adjacent tissues from clinical patients analyzed by IHC. (D) IHC scores of BUB1 between HCC tissues and adjacent tissues from clinical patients. (E) Correlation analysis of BUB1 and Ki-67 IHC scores in tumor tissues of patients with HCC. (F) Correlation analysis of BUB1 and FOXM1 IHC scores in tumor tissues of patients with HCC. (G) Co-IP analysis of the interaction between FOXM1 and BUB1 in HUH7 cells. (H) Effects of FOXM1 shRNA and BUB1 shRNA on the expression of FOXM1 and BUB1 analyzed by Q-PCR. (I) The expression of FOXM1 and BUB1 analyzed by Western blot. (J) ChIP-qPCR analysis of the binding of FOXM1 and BUB1 promoter in HUH7 cells. (K) The sequences at the -293 bp of the BUB1-WT promoter and the BUB1-Mut promoter. (L) The binding of FOXM1 and BUB1 promoter at the -293 bp sequence GTAAACC analyzed by dual luciferase reporter assay. (M) Q-PCR analysis of BUB1 expression in different HCC cells. (N) Western blot analysis of BUB1 expression in different HCC cells. (O) KEGG pathway enrichment analysis of top 50 targets in the PPI network of BUB1. (P) Venn diagram of overlapping genes identified by RNA-seq, FOXM1 PPI network, and BUB1 PPI network. (Q) correlation analysis of BUB1 expression and LIHC cell stemness in TCGA. (R) Effect of BUB1 on the inhibitory role of FOXM1 shRNA in the proliferation of HUH7 cells. (S) Effects of BUB1 on the inhibition of FOXM1 shRNA in HUH7 colony formation. (T) Effects of BUB1 on the promotion of FOXM1 shRNA in HUH7 cell apoptosis. (U) Effects of BUB1 shRNA on HUH7 xenograft tumor volumes. (V) Photos of HUH7 xenograft tumors in each group. (W) Effects of BUB1 shRNA on HUH7 xenograft tumor weight. (X) Effects of BUB1 shRNA on Ki-67 and BUB1 expression in each group. Images were randomly selected from five replicates. Data from three independent experiments were analyzed by one-way ANOVA: * P<0.05, ** P<0.01 vs. NC KD group, # P < 0.05, ## P < 0.01 vs. FOXM1 KD group.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: Expressing, RNA Sequencing, Gene Expression, Co-Immunoprecipitation Assay, shRNA, Western Blot, ChIP-qPCR, Binding Assay, Sequencing, Luciferase, Reporter Assay, Inhibition

Knockdown of BUB1 enhances HCC cell sensitivity to FOXM1 inhibitor FDI-6. (A) Effect of BUB1 shRNA on FDI-6-mediated inhibition of colony formation in HUH7 cells. (B) Effect of BUB1 shRNA on FDI-6-induced apoptosis. (C) Effect of BUB1 shRNA on FDI-6-induced DNA damage. (D) Effect of BUB1 shRNA on the G2/M phase arrest caused by FDI-6. (E) Western blot analysis of BUB1 shRNA and FDI-6 effects on DNA repair-related gene expression. (F) Western blot analysis of BUB1 shRNA and FDI-6 effects on cell cycle-related gene expression. (G) IF analysis of BUB1 shRNA and FDI-6 effects on CD44 expression. (H) Western blot analysis of BUB1 shRNA and FDI-6 effects on stemness-related gene expression. (I) Effects of BUB1 shRNA on FDI-6 mediated suppression of HCC cell invasion and migration. (J) Western blot analysis of BUB1 shRNA and FDI-6 effects on EMT-related gene expression. (K) Effects of BUB1 shRNA and FDI-6 on mouse weight. (L) Effects of BUB1 shRNA and FDI-6 on tumor volume. (M) The photos of HUH7 xenograft tumors in each group. (N) Effects of BUB1 shRNA and FDI-6 on tumor weight. (O) The inhibition ratios of BUB1 shRNA and FDI-6 on tumor volume and weight. (P) IHC analysis of the effects of BUB1 shRNA and FDI-6 on Ki-67 and FOXM1 expression Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P<0.05, ** P<0.01 vs. NC KD group, # P < 0.05, ## P < 0.01 vs. BUB1 KD+FDI-6 group.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: Knockdown of BUB1 enhances HCC cell sensitivity to FOXM1 inhibitor FDI-6. (A) Effect of BUB1 shRNA on FDI-6-mediated inhibition of colony formation in HUH7 cells. (B) Effect of BUB1 shRNA on FDI-6-induced apoptosis. (C) Effect of BUB1 shRNA on FDI-6-induced DNA damage. (D) Effect of BUB1 shRNA on the G2/M phase arrest caused by FDI-6. (E) Western blot analysis of BUB1 shRNA and FDI-6 effects on DNA repair-related gene expression. (F) Western blot analysis of BUB1 shRNA and FDI-6 effects on cell cycle-related gene expression. (G) IF analysis of BUB1 shRNA and FDI-6 effects on CD44 expression. (H) Western blot analysis of BUB1 shRNA and FDI-6 effects on stemness-related gene expression. (I) Effects of BUB1 shRNA on FDI-6 mediated suppression of HCC cell invasion and migration. (J) Western blot analysis of BUB1 shRNA and FDI-6 effects on EMT-related gene expression. (K) Effects of BUB1 shRNA and FDI-6 on mouse weight. (L) Effects of BUB1 shRNA and FDI-6 on tumor volume. (M) The photos of HUH7 xenograft tumors in each group. (N) Effects of BUB1 shRNA and FDI-6 on tumor weight. (O) The inhibition ratios of BUB1 shRNA and FDI-6 on tumor volume and weight. (P) IHC analysis of the effects of BUB1 shRNA and FDI-6 on Ki-67 and FOXM1 expression Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P<0.05, ** P<0.01 vs. NC KD group, # P < 0.05, ## P < 0.01 vs. BUB1 KD+FDI-6 group.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: Knockdown, shRNA, Inhibition, Western Blot, Gene Expression, Expressing, Migration

FOXM1 inhibitors and BAY synergistically inhibit proliferation of HCC cells and tumors. (A) Effect of BAY and FDI-6 on the proliferation of HUH7 cells. (B) The CI values of the combinations of BAY and FDI-6 at different concentration ratios. (C) Effect of BAY, FDI-6 and their combination on the colony formation of HUH7 cells. (D) Effect of BAY, FDI-6 and their combination on the apoptosis of HUH7 cells. (E) The CI values of the combinations of TST and FDI-6 at different concentration ratios. (F) Effect of TST, FDI-6 and their combination on the colony formation of HUH7 cells. (G) The CI values of the combinations of RCM-1 and FDI-6 at different concentration ratios. (H) Effect of RCM-1, FDI-6 and their combination on the colony formation of HUH7 cells. (I) Effect of BAY, FDI-6 and their sequential combination on tumor volume. (J) Effect of BAY, FDI-6 and their sequential combination on tumor weight. (K) The photos of HUH7 xenograft tumors in each group. (L) Acute toxicity analysis of 100 mg/kg FDI-6, 100 mg/kg BAY, and their combination in mice. (M) Effect of BAY, FDI-6 and their sequential combination on mouse weight. (N) Effect of BAY, FDI-6 and their sequential combination on the heart, liver, spleen, lung and kidney in mice. (O) Effect of BAY, FDI-6 and their sequential combination on the expression of Ki-67, FOXM1, and BUB1 in HUH7 xenograft tumors. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P<0.05, ** P<0.01 vs. control group, # P < 0.05, ## P < 0.01 vs. BAY-FDI-6 group.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: FOXM1 inhibitors and BAY synergistically inhibit proliferation of HCC cells and tumors. (A) Effect of BAY and FDI-6 on the proliferation of HUH7 cells. (B) The CI values of the combinations of BAY and FDI-6 at different concentration ratios. (C) Effect of BAY, FDI-6 and their combination on the colony formation of HUH7 cells. (D) Effect of BAY, FDI-6 and their combination on the apoptosis of HUH7 cells. (E) The CI values of the combinations of TST and FDI-6 at different concentration ratios. (F) Effect of TST, FDI-6 and their combination on the colony formation of HUH7 cells. (G) The CI values of the combinations of RCM-1 and FDI-6 at different concentration ratios. (H) Effect of RCM-1, FDI-6 and their combination on the colony formation of HUH7 cells. (I) Effect of BAY, FDI-6 and their sequential combination on tumor volume. (J) Effect of BAY, FDI-6 and their sequential combination on tumor weight. (K) The photos of HUH7 xenograft tumors in each group. (L) Acute toxicity analysis of 100 mg/kg FDI-6, 100 mg/kg BAY, and their combination in mice. (M) Effect of BAY, FDI-6 and their sequential combination on mouse weight. (N) Effect of BAY, FDI-6 and their sequential combination on the heart, liver, spleen, lung and kidney in mice. (O) Effect of BAY, FDI-6 and their sequential combination on the expression of Ki-67, FOXM1, and BUB1 in HUH7 xenograft tumors. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P<0.05, ** P<0.01 vs. control group, # P < 0.05, ## P < 0.01 vs. BAY-FDI-6 group.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: Concentration Assay, Expressing, Control

FOXM1/BUB1 axis drives HCC cell DNA repair, G2/M transition, stemness, migration, and invasion. (A) Effect of BAY, FDI-6 and their combination on DNA damage in HUH7 cells. (B) Effect of BAY, FDI-6 and their combination on DNA repair-related genes in HUH7 cells analyzed by Q-PCR. (C) Effect of BAY, FDI-6 and their combination on cell cycle progression in HUH7 cells. (D) Effect of BAY, FDI-6 and their combination on cell cycle-related genes in HUH7 cells analyzed by Q-PCR. (E) Effect of BAY, FDI-6 and their combination on CD44 expression in HUH7 cells analyzed by IF. (F) Q-PCR analysis of the effects of BAY, FDI-6 and their combination on the expression of cell cycle-related genes in HUH7 cells. (G) Effect of BAY, FDI-6 and their combination on the formation of HUH7 spheres. (H) Effect of BAY, FDI-6 and their combination on the migration and invasion of HUH7 cells. (I) Q-PCR analysis of the effects of BAY, FDI-6 and their combination on the expression of EMT-related genes in HUH7 cells. (J) The molecular mechanism of the FOXM1/BUB1 axis in regulating HCC malignancy. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P<0.05, ** P<0.01 vs. control group, # P < 0.05, ## P < 0.01 vs. BAY-FDI-6 group.

Journal: International Journal of Biological Sciences

Article Title: Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma

doi: 10.7150/ijbs.125454

Figure Lengend Snippet: FOXM1/BUB1 axis drives HCC cell DNA repair, G2/M transition, stemness, migration, and invasion. (A) Effect of BAY, FDI-6 and their combination on DNA damage in HUH7 cells. (B) Effect of BAY, FDI-6 and their combination on DNA repair-related genes in HUH7 cells analyzed by Q-PCR. (C) Effect of BAY, FDI-6 and their combination on cell cycle progression in HUH7 cells. (D) Effect of BAY, FDI-6 and their combination on cell cycle-related genes in HUH7 cells analyzed by Q-PCR. (E) Effect of BAY, FDI-6 and their combination on CD44 expression in HUH7 cells analyzed by IF. (F) Q-PCR analysis of the effects of BAY, FDI-6 and their combination on the expression of cell cycle-related genes in HUH7 cells. (G) Effect of BAY, FDI-6 and their combination on the formation of HUH7 spheres. (H) Effect of BAY, FDI-6 and their combination on the migration and invasion of HUH7 cells. (I) Q-PCR analysis of the effects of BAY, FDI-6 and their combination on the expression of EMT-related genes in HUH7 cells. (J) The molecular mechanism of the FOXM1/BUB1 axis in regulating HCC malignancy. Images were randomly selected from five replicates. Data from three independent experiments were statistically analyzed using one-way ANOVA: * P<0.05, ** P<0.01 vs. control group, # P < 0.05, ## P < 0.01 vs. BAY-FDI-6 group.

Article Snippet: The differential expression of FOXM1 in HCC tissues and adjacent normal tissues from the human protein atlas was analyzed using the online tool ( https://www.proteinatlas.org/ ).

Techniques: Migration, Expressing, Control